METHYLPREDNISOLONE VIATRIS 500 mg, powder for solution for injection 10 bottles
Active ingredients: Methylprednisolone hemisuccinate, Methylprednisolone
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Powder for solution for injection10 bottlesintraveineuse
Supply resumed
Package details
Original BDPM fields are shown in French.
- Official name
- METHYLPREDNISOLONE VIATRIS 500 mg, poudre pour solution injectable
- Pharmaceutical form
- poudre pour solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 10 flacon(s) en verre
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Jan 1997
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62628873CIP73554058CIP133400935540584Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉTHYLPREDNISOLONEpoudre | 500,00 mg · un flacon de lyophilisat | FT |
| HÉMISUCCINATE DE MÉTHYLPREDNISOLONEpoudre | 633,50 mg · un flacon de lyophilisat | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.